CompletedNot applicableNCT03492970
Melatonin in Adults With SMS
Studying Smith-Magenis syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hôpital le Vinatier
- Principal Investigator
- POISSON ALICE, PHCH LE VINATIER
- Intervention
- Hourly dosing of the nychtemeral secretion of melatonin(biological)
- Enrollment
- 10 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2018 – 2019
Study locations (1)
- CH Le Vinatier, Bron, Auvergne-Rhône-Alpes, France
Collaborators
Hospices Civils de Lyon
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03492970 on ClinicalTrials.govOther trials for Smith-Magenis syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05116904Smith Magenis Syndrome and Autism Spectrum DisordersHospices Civils de Lyon
- RECRUITINGNCT03154697Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep DisturbancesVanda Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT00013559Natural History Study of Smith-Magenis SyndromeNational Human Genome Research Institute (NHGRI)